PMS-NABILONE

Pharmascience Inc🇨🇦 Health Canada

Approval Id: b88370a1d5ed2323
Drug Approval Canada Name: PMS-NABILONE
Product Name: PMS-NABILONE
Status: Marketed
Status Date: 2021-01-22
Original Market Date: 2021-01-22
Din: 02380897
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Narcotic (CDSA II)
Ahfs: 56:22.92
Atc Original: A04AD11 NABILONE
Atc Name: a 04 ad 11
Aig Number: 0115009003
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

NABILONE

0.25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b88370a1d5ed2323

Type

Standard